superphosphate fertilizer

superphosphate fertilizer

Sweden's women's soccer team delivered a commanding 6-0 victory over Serbia, securing their place in next year's Women's European Championship finals in Switzerland. This triumph concluded an 8-0 aggregate victory, ensuring Sweden's participation alongside Nordic neighbors Norway and Finland, who also emerged victorious in Tuesday's playoffs. With seven spots up for grabs, 12,378 fans in Stockholm witnessed a stunning first-half display that dashed Serbian hopes. Filippa Angeldahl opened the scoring with a penalty, followed by Kosovare Asllani and Stina Blackstenius adding to the lead. Midfielder Hanna Bennison added another, and Anna Anvegaard sealed the win, as the Swedes celebrated with a tribute to Caroline Seger. Elsewhere, Norway and Finland secured qualification with respective wins over Northern Ireland and Scotland. Portugal and Poland also advanced with narrow victories. Upcoming matches feature Belgium against Ukraine, and Ireland versus Wales in the final qualifiers. (With inputs from agencies.)The African Conference on Precision Agriculture (AfCPA), a transformative event aimed at driving agricultural innovation across the continent, has launched simultaneously in 10 African nations, with Egypt taking a prominent role as one of the satellite hosts. The Egyptian session, organized by the National Authority for Remote Sensing and Space Sciences (NARSS), aligns with the overarching mission of promoting precision agriculture as a foundation for sustainable food security and economic growth across Africa. In his opening remarks, Islam Aboulmajd, Chairperson of NARSS, underscored Egypt’s leadership in advancing agricultural technology. He highlighted the government’s investments in digital transformation and agricultural research as part of its strategy to address critical food security challenges. “Africa possesses fertile land, abundant water resources, and a dynamic youth population, all of which are essential to securing the world’s future food supply. This conference creates a platform for collaboration among scientists, practitioners, and policymakers to realize this potential,” Aboulmajd stated. Mohamed Aboelghar, Head of Agricultural Applications at NARSS, noted the continent’s capacity to boost agricultural productivity by 70% by 2050 through innovations like the Internet of Things (IoT). However, he also pointed out significant hurdles, including climate change, soil degradation, and inefficiencies in large-scale farming practices. “This forum provides a vital opportunity for African experts to share knowledge and collectively tackle these challenges,” Aboelghar emphasized. The AfCPA highlights the urgent need to adopt precision agriculture to mitigate the effects of global warming and maximize resource efficiency. The agenda features expert-led lectures, collaborative discussions, and case studies designed to shape policies for scaling sustainable practices continent-wide. Egypt’s active participation reflects its dedication to fostering regional and international partnerships. Over the next three days, the conference aims to produce actionable recommendations to support a food-secure and sustainable future for Africa.

US lawmakers concluded a two-year investigation Monday into the Covid-19 outbreak that killed 1.1 million Americans -- backing the theory that the virus likely leaked from a Chinese laboratory. A 520-page report from the Republican-controlled House Select Subcommittee on the Coronavirus Pandemic looked at the federal and state-level response, as well as the pandemic's origins and vaccination efforts. "This work will help the United States, and the world, predict the next pandemic, prepare for the next pandemic, protect ourselves from the next pandemic, and hopefully prevent the next pandemic," panel chairman Brad Wenstrup said in a letter to Congress. US federal agencies, the World Health Organization and scientists across the planet have arrived at different conclusions about the most likely origin of Covid-19, and no consensus has emerged. Most believe it to have spread from animals in China, but a US intelligence analysis said last year that the virus may have been genetically engineered and escaped from a virology lab in the Chinese city of Wuhan, where human cases first emerged. The congressional panel was persuaded by the lab leak theory after meeting 25 times, conducting more than 30 transcribed interviews and reviewing more than one million pages of documents. The investigation included two days of interviews behind closed doors with Anthony Fauci, the government scientist who became the nation's most trusted expert in the chaotic early days of the 2020 outbreak. Fauci's clashes with former and incoming president Donald Trump over the response sparked fury on the right, and he now lives with security protection following death threats against his family. Republicans accuse the 83-year-old immunologist of helping to set off the worst pandemic in a century by approving funding passed on to Chinese scientists they accuse of manufacturing the SARS-CoV-2 coronavirus that causes Covid-19. Among its headline conclusions, the report said the National Institutes of Health had indeed funded contentious "gain-of-function" research -- which seeks to enhance viruses as a way of finding ways to combat them -- at the Wuhan Institute of Virology. Fauci angrily denied covering up the origins of Covid-19 before the panel in June, arguing that it would be "molecularly impossible" for the bat viruses studied at the lab to be turned into the virus that caused the pandemic. But the panel's report said SARS-CoV-2 "likely emerged because of a laboratory or research related accident." The probe found that lockdowns "did more harm than good" and that mask mandates were "ineffective at controlling the spread of Covid-19," contradicting other research showing that masking in public does reduce transmission rates. Social distancing guidelines also came under criticism, although travel restrictions were deemed to have saved lives. Investigators found that Trump's Operation Warp Speed -- the publicly-funded project to develop Covid vaccines -- was a "tremendous success" but that school closures would have an "enduring impact" on US children. ft/jgcHammond Power Solutions Declares Quarterly Dividend

Arkansas visits skidding Miami in battle of veteran coaches

Toronto, Dec 3 (AP) Prime Minister Justin Trudeau told Donald Trump that Americans would also suffer if the president-elect follows through on a plan to impose sweeping tariffs on Canadian products, a Canadian minister who attended their recent dinner said Monday. Trump threatened to impose tariffs on products from Canada and Mexico if they don't stop what he called the flow of drugs and migrants across their borders with the United States. He said on social media last week that he would impose a 25% tax on all products entering the U.S. from Canada and Mexico as one of his first executive orders. Canadian Public Safety Minister Dominic LeBlanc, whose responsibilities include border security, attended a dinner with Trump and Trudeau at Trump's Mar-a-Lago club on Friday. Trudeau requested the meeting in a bid to avoid the tariffs by convincing Trump that the northern border is nothing like the U.S. southern border with Mexico. "The prime minister of course spoke about the importance of protecting the Canadian economy and Canadian workers from tariffs, but we also discussed with our American friends the negative impact that those tariffs could have on their economy, on affordability in the United States as well," LeBlanc said in Parliament. If Trump makes good on his threat to slap 25% tariffs on everything imported from Mexico and Canada, the price increases that could follow will collide with his campaign promise to give American families a break from inflation. Economists say companies would have little choice but to pass along the added costs, dramatically raising prices for food, clothing, automobiles, alcohol and other goods. The Produce Distributors Association, a Washington trade group, said last week that tariffs will raise prices for fresh fruit and vegetables and hurt U.S. farmers when the countries retaliate. Canada is already examining possible retaliatory tariffs on certain items from the U.S. should Trump follow through on the threat. After his dinner with Trump, Trudeau returned home without assurances the president-elect will back away from threatened tariffs on all products from the major American trading partner. Trump called the talks “productive” but signaled no retreat from a pledge that Canada says unfairly lumps it in with Mexico over the flow of drugs and migrants into the United States. “The idea that we came back empty handed is completely false,” LeBlanc said. “We had a very productive discussion with Mr. Trump and his future Cabinet secretaries. ... The commitment from Mr. Trump to continue to work with us was far from empty handed.” Joining Trump and Trudeau at dinner were Howard Lutnick, Trump's nominee for commerce secretary, North Dakota Gov. Doug Burgum, Trump's pick to lead the Interior Department, and Mike Waltz, Trump's choice to be his national security adviser. Canada's ambassador to the U.S., Kirsten Hillman, told The Associated Press on Sunday that “the message that our border is so vastly different than the Mexican border was really understood.” Hillman, who sat at an adjacent table to Trudeau and Trump, said Canada is not the problem when it comes to drugs and migrants. On Monday, Mexico's president rejected those comments. “Mexico must be respected, especially by its trading partners,” President Claudia Sheinbaum said. She said Canada had its own problems with fentanyl consumption and “could only wish they had the cultural riches Mexico has.” Flows of migrants and seizures of drugs at the two countries' border are vastly different. U.S. customs agents seized 43 pounds of fentanyl at the Canadian border during the last fiscal year, compared with 21,100 pounds at the Mexican border. Most of the fentanyl reaching the U.S. — where it causes about 70,000 overdose deaths annually — is made by Mexican drug cartels using precursor chemicals smuggled from Asia. On immigration, the U.S. Border Patrol reported 1.53 million encounters with migrants at the southwest border with Mexico between October 2023 and September 2024. That compares to 23,721 encounters at the Canadian border during that time. Canada is the top export destination for 36 U.S. states. Nearly $3.6 billion Canadian (US$2.7 billion) worth of goods and services cross the border each day. About 60% of U.S. crude oil imports are from Canada, and 85% of U.S. electricity imports as well. Canada is also the largest foreign supplier of steel, aluminum and uranium to the U.S. and has 34 critical minerals and metals that the Pentagon is eager for and investing for national security.(AP) NB NB (This story has not been edited by THE WEEK and is auto-generated from PTI)

Trump to attend Notre-Dame Cathedral reopeningEdmonton visits Colorado after shootout winJets aren’t ready to send Aaron Rodgers to the sideline as a lost season reaches the home stretch

Best-Selling Author Under Fire For “Insulting” Daughter’s K-Pop Fandom, Responds To CriticismOliver Glasner: Crystal Palace are heading in right direction after Ipswich winValladolid loses again and Getafe ends winless run in La Liga

Advisors Asset Management Inc. raised its holdings in shares of Crinetics Pharmaceuticals, Inc. ( NASDAQ:CRNX – Free Report ) by 56.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,806 shares of the company’s stock after buying an additional 1,008 shares during the period. Advisors Asset Management Inc.’s holdings in Crinetics Pharmaceuticals were worth $143,000 at the end of the most recent reporting period. A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Driehaus Capital Management LLC boosted its holdings in Crinetics Pharmaceuticals by 17.0% during the 2nd quarter. Driehaus Capital Management LLC now owns 6,112,173 shares of the company’s stock valued at $273,764,000 after acquiring an additional 885,876 shares during the period. Vanguard Group Inc. lifted its position in Crinetics Pharmaceuticals by 2.1% in the first quarter. Vanguard Group Inc. now owns 3,575,076 shares of the company’s stock valued at $167,349,000 after purchasing an additional 72,624 shares during the last quarter. Jennison Associates LLC boosted its stake in shares of Crinetics Pharmaceuticals by 0.5% during the third quarter. Jennison Associates LLC now owns 2,793,614 shares of the company’s stock valued at $142,754,000 after purchasing an additional 13,470 shares during the period. BNP PARIBAS ASSET MANAGEMENT Holding S.A. grew its holdings in shares of Crinetics Pharmaceuticals by 0.6% in the second quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 546,234 shares of the company’s stock worth $24,466,000 after purchasing an additional 3,526 shares during the last quarter. Finally, Affinity Asset Advisors LLC grew its holdings in shares of Crinetics Pharmaceuticals by 9.6% in the second quarter. Affinity Asset Advisors LLC now owns 515,000 shares of the company’s stock worth $23,067,000 after purchasing an additional 45,000 shares during the last quarter. 98.51% of the stock is owned by institutional investors. Insider Transactions at Crinetics Pharmaceuticals In other news, COO Jeff E. Knight sold 501 shares of Crinetics Pharmaceuticals stock in a transaction that occurred on Friday, November 22nd. The shares were sold at an average price of $56.52, for a total transaction of $28,316.52. Following the completion of the transaction, the chief operating officer now directly owns 51,653 shares in the company, valued at approximately $2,919,427.56. This trade represents a 0.96 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website . Also, CFO Marc Wilson sold 25,000 shares of the company’s stock in a transaction that occurred on Thursday, September 26th. The stock was sold at an average price of $51.11, for a total value of $1,277,750.00. Following the completion of the sale, the chief financial officer now owns 111,092 shares in the company, valued at $5,677,912.12. The trade was a 18.37 % decrease in their position. The disclosure for this sale can be found here . Insiders have sold 40,911 shares of company stock valued at $2,144,675 in the last three months. 6.00% of the stock is currently owned by company insiders. Crinetics Pharmaceuticals Stock Performance Crinetics Pharmaceuticals ( NASDAQ:CRNX – Get Free Report ) last issued its quarterly earnings results on Tuesday, November 12th. The company reported ($0.96) earnings per share for the quarter, missing the consensus estimate of ($0.91) by ($0.05). During the same period in the prior year, the firm earned ($1.01) earnings per share. On average, equities analysts forecast that Crinetics Pharmaceuticals, Inc. will post -3.75 EPS for the current fiscal year. Wall Street Analysts Forecast Growth Several brokerages have weighed in on CRNX. Cantor Fitzgerald reissued an “overweight” rating and set a $90.00 price target on shares of Crinetics Pharmaceuticals in a research report on Monday, September 16th. JMP Securities reiterated a “market outperform” rating and set a $80.00 target price on shares of Crinetics Pharmaceuticals in a report on Friday, September 27th. Oppenheimer restated an “outperform” rating and set a $73.00 price target (down previously from $74.00) on shares of Crinetics Pharmaceuticals in a report on Friday, August 9th. Citigroup upped their price target on Crinetics Pharmaceuticals from $70.00 to $74.00 and gave the company a “buy” rating in a research report on Thursday, November 14th. Finally, HC Wainwright lifted their price objective on Crinetics Pharmaceuticals from $69.00 to $81.00 and gave the stock a “buy” rating in a research report on Wednesday, November 13th. One research analyst has rated the stock with a hold rating and ten have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $70.18. Get Our Latest Stock Report on CRNX Crinetics Pharmaceuticals Company Profile ( Free Report ) Crinetics Pharmaceuticals, Inc, a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's lead product candidate is paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist, which is in Phase 3 trial for the treatment of acromegaly; and Phase 2 trial for treating carcinoid syndrome associated with neuroendocrine tumors. Featured Stories Five stocks we like better than Crinetics Pharmaceuticals 3 Fintech Stocks With Good 2021 Prospects The Latest 13F Filings Are In: See Where Big Money Is Flowing Which Wall Street Analysts are the Most Accurate? 3 Penny Stocks Ready to Break Out in 2025 Airline Stocks – Top Airline Stocks to Buy Now FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential Receive News & Ratings for Crinetics Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crinetics Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter .Harris: Fine Gael ‘will gain seats’ amid further fragmentation of Irish politics

None

Lost in the manosphere

Got a movie buff on your holiday gift list that seems to have everything? Amazon is offering a great bundle deal where you'll get both a Sony Bravia 7 and a Sony Bravia Bar 8. Depending on the TV size you chose, you could save up to $1,100 that you could put towards rounding out your home theater with a vinyl setup or a PlayStation 5 Pro to take advantage of exclusive gaming features. Also: The best Black Friday deals live now The Sony Bravia 7 is the brand's latest update to their mid-range lineup of mini LED TVs. With Dolby Vision HDR support, you'll get enhanced detailing and contrast while the 120Hz refresh rate gives you smoother motion during fast-paced movie and TV show scenes, sports broadcasts, and video games. And with Dolby Atmos, you'll get virtual surround sound audio for a more immersive experience. Also: The best Sony TVs you can buy: Expert tested The Bravia 7 uses the Google TV platform to give you access to a preloaded suite of popular streaming apps like Netflix, Hulu, and Disney+, as well as everything you need to turn your home theater into the ultimate entertainment hub. You'll also get built-in Google Assistant voice controls for hands-free use of your new TV; you can also use an Alexa account if you prefer Amazon's virtual assistant. Native support for both Apple AirPlay and Google Chromecast allows you to share photos, video, and music from iOS and Android devices for more ways to entertain family and friends. Read more: The best soundbars you can buy: Tested and reviewed And to boost the Bravia 7's already impressive audio, this bundle includes the Sony Bravia Bar 8 , an 11-channel sound bar with support for spatial audio without having to set up satellite speakers. Built-in microphones allow the sound bar to actively monitor ambient sound in the room and automatically calibrate audio settings to the room's size, acoustic design, and even where you're sitting to provide the best experience. It even has a 4K passthrough with Dolby Vision and variable refresh rate support so you can connect game consoles for smoother video. When will this deal expire? While Amazon hasn't put a hard and fast end date on this bundle deal, you won't want to wait around to take advantage of the savings because stock may be limited at this price. Best VPN services Best robot vacuums and mops The best phones you can buy (and how the iPhone 16 Pro Max compares) The best laptops you can buy: Expert tested